Keybanc analyst Tim Rezvan initiates coverage on EOG Resources (NYSE:EOG) with a Overweight rating and announces Price Target of $157.
FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation For Hepatorenal Syndrome
SeaStar Medical Holding Corporation (NASDAQ:ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces receipt of U.S. Food and Drug
